Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F8Y3X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,784
Award facts
- Contract value 100% obligated
- $18,783.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $18,783.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, issued on October 30, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's federal medical procurement activities.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded delivery orders through the DLA Medical Supply Chain, supplying pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current award for Mounjaro, a diabetes medication, reflects the company's ongoing role in supporting federal healthcare requirements and demonstrates its capability to deliver specialized pharmaceutical products through firm fixed-price mechanisms.
Quick answers
Who was awarded contract SPE2DR26F8Y3X?
SPE2DR26F8Y3X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26F8Y3X worth?
The government has obligated $18,784 on SPE2DR26F8Y3X.
Is contract SPE2DR26F8Y3X an order under another contract?
Yes. SPE2DR26F8Y3X is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y3X competed?
The extent of competition for SPE2DR26F8Y3X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award